OR2AT4 and OR1A2 counterregulate molecular pathophysiological processes of steroid-resistant inflammatory lung diseases in human alveolar macrophages
Abstract Background Therapeutic options for steroid-resistant non-type 2 inflammation in obstructive lung diseases are lacking. Alveolar macrophages are central in the progression of these diseases by releasing proinflammatory cytokines, making them promising targets for new therapeutic approaches....
Saved in:
Main Authors: | Daniel Weidinger (Author), Kaschin Jamal Jameel (Author), Desiree Alisch (Author), Julian Jacobsen (Author), Paul Bürger (Author), Matthias Ruhe (Author), Faisal Yusuf (Author), Simon Rohde (Author), Klemens Störtkuhl (Author), Peter Kaufmann (Author), Juliane Kronsbein (Author), Marcus Peters (Author), Hanns Hatt (Author), Nikolaos Giannakis (Author), Jürgen Knobloch (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes
by: Emily G. Hoffman, et al.
Published: (2024) -
Effects of Quinine, Quinidine and Chloroquine on Human Muscle Nicotinic Acetylcholine Receptors
by: Günter Gisselmann, et al.
Published: (2018) -
12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
by: Alexa R. Lindley, et al.
Published: (2010) -
2-Aminoethoxydiphenyl borate activates the human mechano-gated KCNK channels KCNK 2 (TREK-1), KCNK 4 (TRAAK) and KCNK 10 (TREK-2).
by: Leopoldo Raul Beltran, et al.
Published: (2013) -
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
by: Rikke Nørregaard, et al.
Published: (2015)